Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 108

    1.

    Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin).

    Gibran SK, Sachdev A, Stappler T, Newsome R, Wong D, Hiscott P.

    Br J Ophthalmol. 2007 May;91(5):602-4. Epub 2006 Dec 13.PMID: 17166893 [PubMed - indexed for MEDLINE]Related articles

    2.

    Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.

    Chan CK, Meyer CH, Gross JG, Abraham P, Nuthi AS, Kokame GT, Lin SG, Rauser ME, Kaiser PK.

    Retina. 2007 Jun;27(5):541-51.PMID: 17558314 [PubMed - indexed for MEDLINE]Related articles

    3.

    Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

    Ronan SM, Yoganathan P, Chien FY, Corcóstegui IA, Blumenkranz MS, Deramo VA, Elner SG, Fastenberg DA, Johnson MW, López M, Mateo C, Moshfeghi DM, Navarro R, Rosenblatt BJ, Sanislo SR, Saxe SJ, Zacks DN.

    Retina. 2007 Jun;27(5):535-40.PMID: 17558313 [PubMed - indexed for MEDLINE]Related articles

    4.

    [The effect of bevacizumab on the ultrastructure of choroidal neovascular membranes in patients with age-related macular degeneration (AMD)]

    Vidinova C, Vidinov N.

    Klin Monbl Augenheilkd. 2009 Jun;226(6):491-5. Epub 2009 Jun 8. German. PMID: 19507100 [PubMed - indexed for MEDLINE]Related articles

    5.

    Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

    Retina. 2007 Apr-May;27(4):432-8.PMID: 17420694 [PubMed - indexed for MEDLINE]Related articles

    6.

    A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations.

    Algvere PV, Steén B, Seregard S, Kvanta A.

    Acta Ophthalmol. 2008 Aug;86(5):482-9. Epub 2007 Dec 14.PMID: 18162062 [PubMed - indexed for MEDLINE]Related articles

    7.

    Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration.

    Lazic R, Gabric N.

    Graefes Arch Clin Exp Ophthalmol. 2007 Jan;245(1):68-73. Epub 2006 Nov 18.PMID: 17111146 [PubMed - indexed for MEDLINE]Related articles

    8.

    Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.

    Melamud A, Stinnett S, Fekrat S.

    Am J Ophthalmol. 2008 Jul;146(1):91-5. Epub 2008 May 2.PMID: 18455144 [PubMed - indexed for MEDLINE]Related articles

    9.

    Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration.

    Garg S, Brod R, Kim D, Lane RG, Maguire J, Fischer D.

    Clin Experiment Ophthalmol. 2008 Apr;36(3):252-6.PMID: 18412594 [PubMed - indexed for MEDLINE]Related articles

    10.

    Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin).

    Nicolò M, Ghiglione D, Calabria G.

    Eur J Ophthalmol. 2006 Sep-Oct;16(5):770-3.PMID: 17061236 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: a short-term study.

    Chen CY, Wong TY, Heriot WJ.

    Am J Ophthalmol. 2007 Mar;143(3):510-2. Epub 2006 Nov 13.PMID: 17317398 [PubMed - indexed for MEDLINE]Related articles

    12.

    Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.

    Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA; Pan-American Collaborative Retina Study Group.

    Retina. 2008 Nov-Dec;28(10):1387-94.PMID: 18827735 [PubMed - indexed for MEDLINE]Related articles

    13.

    Macular relocation after photodynamic therapy for recurrent choroidal neovascular membrane: visual results and histopathological findings.

    Stanga P, Hiscott P, Li K, Wong D.

    Br J Ophthalmol. 2003 Aug;87(8):975-6.PMID: 12881338 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease.

    Wong LJ, Desai RU, Jain A, Feliciano D, Moshfeghi DM, Sanislo SR, Blumenkranz MS.

    Retina. 2008 Oct;28(8):1151-8.PMID: 18685542 [PubMed - indexed for MEDLINE]Related articles

    16.

    Retinal pigment epithelial tears after intravitreal bevacizumab injection for predominantly classic choroidal neovascularization.

    Arias L, Caminal JM, Rubio M, Pujol O, Arruga J.

    Eur J Ophthalmol. 2007 Nov-Dec;17(6):992-5.PMID: 18050131 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.

    Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT, Emerson GG, Schlesinger TK, Nolte SK, Klein ML.

    Retina. 2007 Apr-May;27(4):439-44.PMID: 17420695 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study.

    Costa RA, Jorge R, Calucci D, Cardillo JA, Melo LA Jr, Scott IU.

    Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4569-78.PMID: 17003454 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study.

    Bashshur ZF, Haddad ZA, Schakal A, Jaafar RF, Saab M, Noureddin BN.

    Am J Ophthalmol. 2008 Feb;145(2):249-256. Epub 2007 Dec 11.PMID: 18067876 [PubMed - indexed for MEDLINE]Related articles

    20.

    Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

    Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.PMID: 17186262 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data